Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | StimCell Energetics Launches Social Media Presence | 132 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / January 30, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell", or the "Company"), a biotech company targeting cellular energy to promote anti-aging, longevity... ► Artikel lesen | |
14.01. | Stimcell Energetics Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
08.01. | Stimcell Energetics Inc. - 8-K, Current Report | - | SEC Filings | ||
08.01. | StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing | 180 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / January 8, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell", or the "Company") a biotech company targeting cellular energy to promote anti-aging, longevity and... ► Artikel lesen | |
05.11.24 | Stimcell Energetics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
04.11.24 | Cell MedX Corp. Announces Major Corporate Updates and Rebranding to StimCell Energetics Inc. | 425 | ACCESS Newswire | VANCOUVER, BC / ACCESSWIRE / November 4, 2024 / StimCell Energetics Inc. (formerly "Cell MedX Corp.") (OTC PINK:CMXC) ("StimCell", or the "Company") a biotech company targeting cellular energy to promote... ► Artikel lesen | |
15.10.24 | Cell MedX Corp. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
STIMCELL ENERGETICS Aktie jetzt für 0€ handeln | |||||
29.08.24 | Cell MedX Corp. - 10-K, Annual Report | 1 | SEC Filings | ||
19.03.24 | Cell MedX Corp. Closes Private Placement Financing | 328 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
28.02.24 | Cell MedX Corp. Announces Resignation of Director | 483 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
26.02.24 | Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board | 311 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA | 0,138 | -2,27 % | Sernova Corp: Sernova appoints Haghighat as chair | ||
VITA 34 | 4,100 | -0,49 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
GERATHERM MEDICAL | 3,600 | +1,12 % | Geratherm Medical Aktie: Fortschritte führen zum Erfolg! | Die Geratherm Medical AG, ein Spezialist für medizinische Temperaturmesstechnik, verzeichnet einen vielversprechenden Jahresbeginn 2025. Der Aktienkurs des Unternehmens stieg am 17. Januar auf 3,68... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,200 | +1,52 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,875 | +7,76 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
MEDICLIN | 2,920 | -2,67 % | Mediclin erhöht Prognose - Aktie stark im Plus | Die Mediclin AG hat am Dienstag ihre Prognose für das Geschäftsjahr 2024 angehoben. Das erwartete Konzern-EBIT wurde auf eine Spanne von 48,0 bis 54,0 Millionen Euro erhöht, nachdem zuvor 33,0 bis 39... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
NOVACCESS GLOBAL | - | - | NovAccess Global Inc. - 10-Q, Quarterly Report | ||
VERU | 0,543 | +1,21 % | Veru Inc.: Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY (Semaglutide) for Weight Reduction | -- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on average... ► Artikel lesen | |
LIFEWARD | 1,390 | 0,00 % | LFWD-Aktie erreicht 52-Wochen-Tief bei 1,4 US-Dollar | ||
LIGHT AI | 0,760 | -0,52 % | Light AI Inc.: Light AI Appoints George Reznik CFO and Corporate Secretary | VANCOUVER, BC, Jan. 27, 2025 /CNW/ - Light AI Inc. (CBOE: ALGO) ("Light AI" or the "Company"), a global healthcare technology company focused on developing artificial... ► Artikel lesen | |
EKSO BIONICS | 0,510 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 23,600 | -2,48 % | Why BrightSpring Health Services, Inc. (BTSG) Is Among the Best Booming Stocks to Invest in Now? | ||
FRESENIUS | 36,850 | -0,32 % | Fresenius SE Aktie: Neue Höhenflüge erreicht! | Die Fresenius SE-Aktie zeigt sich derzeit in bemerkenswerter Verfassung und verzeichnet eine positive Entwicklung im XETRA-Handel. Mit einem aktuellen Kurs von 36,80 EUR demonstriert das Papier eine... ► Artikel lesen |